NDC 72789-181
Buspirone Hydrochloride 10 mg tablet
On the label: PD-Rx Pharmaceuticals, Inc.. It's repackaged: PD-Rx Pharmaceuticals, Inc. rebottles it from Oxford Pharmaceuticals, LLC's NDC 69584-092.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Oxford Pharmaceuticals, LLC | Birmingham, AL, United States | Makes it | Problems found, fixed voluntarilyNov 3, 2023 · 3 inspections |
Repackaging site
- PD-Rx Pharmaceuticals Inc., Oklahoma City, OK, United States · repackages it
Recalls
- May 5, 2021 · Class II · Oxford Pharmaceuticals, LLC
Presence of Foreign Tablets/Capsules
Lots: Lot #: C21021A, Exp. 03/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buspirone: every company that makes it
- Form
- tablet, oral
- Strength
- 10 mg
- Approval
- ANDA ANDA075388
- On the market since
- Jul 27, 2020
- Package NDCs
72789-181-90- Official label
- DailyMed (National Library of Medicine), updated Oct 16, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?